Do we think by the by that MSB could get to lurve Novartis?
Ann: Remestemcel-L for COVID-19 MIS-C published in Pediatrics, page-74
-
- There are more pages in this discussion • 350 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.16 |
Change
-0.035(2.94%) |
Mkt cap ! $1.370B | |||
| Open | High | Low | Value | Volume |
| $1.18 | $1.22 | $1.15 | $4.009M | 3.394M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 23629 | $1.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.16 | 42202 | 9 |
View Market Depth
| Last trade - 12.57pm 15/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |